Dr. Avi Weisfogel, the founder of Dental Sleep Masters is pushing the limits in the complex world of sleep apnea. While the negative side effects of sleep apnea becomes more coherent in recent years, breakthrough research offers a new light to the condition. There is a significant connection between sleep apnea and more deadly disorders such as stroke, heart disease and even diabetes. Dr. Avi Weisfogel works with Dental Sleep Masters to give treatment to those suffering from sleep apnea.
Dr. Weisfogel started his dental journey with a bachelors from Rutgers University in psychology and biology. He soon after attended New York University College of Dentistry to obtain a DDS. Dr. Avi Weisfogel has built an impressive amount of experience in sleep diseases and the best and most innovative ways to treat them. These new breakthroughs make Dr. Avi Weisfogel a well sought after expert in her field.
In 1999, Dr. Avi opened a dental office known as Old Bridge Dental Care. He continued to manage this office for more than fifteen years, and has been highlighted as the Best Dentist in his community several times.
Dr. Avi has opened various businesses that are dedicated to the research of sleep disorders and their relation to dentistry. Dental Sleep Masters is a company Dr. Avi founded in 2014 to allow dentist the chance to further explore cures and treatments for sleep apnea.
Most people with a sleep disorder are never diagnosed. Dr. Avi’s goal is to make more people aware of this sleep disorder, so they may get treatment for it to better their quality of life. The kind of plan that Dr. Avi and his team at Dental Sleep Masters has created is going to give doctors the access to certified sleep apnea labs as the work with their patients. This plan will give more access to sleep apneas professionals which will lead to better care for individuals with sleep disorders.
Combining dental and medical research is the driving force behind more treatments to come. Please visit www.dsmelite.com for more information on sleep apnea disorders and its many new treatments.